Global Tuberculosis Report -- 2012.pdf

More documents

Recommendations

Info

INCIDENCE (INCLUDING HIV) INCIDENCE HIV-POSITIVE NOTIFIED NEW AND RELAPSE CASE DETECTIONYEARPOPULATION(MILLIONS)NUMBER(THOUSANDS)RATE aNUMBER(THOUSANDS)RATE a NUMBER RATE a PERCENTAlbania 1990 3 0.8 (0.580–1.1) 24 (18–32) 653 20 81 (61–110)1995 3 0.77 (0.640–0.900) 24 (20–29) 641 20 84 (71–100)2000 3 0.7 (0.590–0.810) 23 (19–26) 604 20 87 (75–100)2005 3 0.59 (0.500–0.680) 19 (16–22) 506 16 86 (74–100)2009 3 0.47 (0.400–0.540) 15 (12–17) 435 14 93 (80–110)2010 3 0.45 (0.380–0.520) 14 (12–16) 431 13 97 (83–110)2011 3 0.42 (0.360–0.490) 13 (11–15) 422 13 100 (87–120)Andorra 1990 < 1 0.026 (0.023–0.030) 50 (44–57) 23 44 87 (77–99)1995 < 1 0.021 (0.019–0.024) 33 (29–37)2000 < 1 0.011 (
YEARPOPULATION(MILLIONS)INCIDENCE (INCLUDING HIV) INCIDENCE HIV-POSITIVE NOTIFIED NEW AND RELAPSE CASE DETECTIONNUMBER(THOUSANDS)RATE aNUMBER(THOUSANDS)RATE a NUMBER RATE a PERCENTGeorgia 1990 5 15 (14–17) 280 (250–312) 0.01 (
Page 2 and 3:
GLOBALTUBERCULOSISREPORT2012
Page 4 and 5:
ContentsAbbreviationsivAcknowledgem
Page 6 and 7:
AcknowledgementsThis report on glob
Page 8 and 9:
WHO Western Pacific RegionShalala A
Page 10 and 11:
Executive SummaryThe World Health O
Page 12 and 13:
CHAPTER 1IntroductionBOX 1.1Basic f
Page 14 and 15:
TABLE 1.1 Targets for the scale-up
Page 16 and 17:
TABLE 1.2 Reporting of data in the
Page 18 and 19:
BOX 2.1Uncertainty in estimates of
Page 20 and 21:
TABLE 2.2 Estimated burden of disea
Page 22 and 23:
FIGURE 2.5 Estimated TB incidence r
Page 24 and 25:
FIGURE B2.2.1Reporting of notificat
Page 26 and 27:
FIGURE 2.8Estimated TB incidence ra
Page 28 and 29:
FIGURE 2.11 Countries (in blue) for
Page 30 and 31:
FIGURE 2.12 Trends in estimated TB
Page 32 and 33:
● producing and widely disseminat
Page 34 and 35:
FIGURE 2.16 Progress in global cove
Page 36 and 37:
BOX 2.6Efforts by the Task Force to
Page 38 and 39:
CHAPTER 3TB case notificationsand t
Page 40 and 41:
BOX 3.1 1Definitions of TB casesDef
Page 42 and 43:
TABLE 3.3 Contribution of public-pr
Page 44 and 45:
BOX 3.4Integrating community-based
Page 46 and 47:
TABLE 3.4 Estimates of the case det
Page 48 and 49:
TABLE 3.5 Treatment success for new
Page 50 and 51:
CHAPTER 4Drug-resistant TBKEY FACTS
Page 52 and 53:
FIGURE 4.2 Percentage of new TB cas
Page 54 and 55:
BOX 4.1Frequencies of resistance to
Page 56 and 57:
FIGURE 4.6 Number of MDR-TB cases e
Page 58 and 59:
FIGURE 4.7Notified cases of MDR-TB
Page 60 and 61:
egimens globally, providing more su
Page 62 and 63:
5.1 Funding for TB care and control
Page 64 and 65:
TABLE 5.2 NTP budgets, available fu
Page 66 and 67:
FIGURE 5.5Trends in domestic and do
Page 68 and 69:
FIGURE 5.6Domestic funding as a per
Page 70 and 71:
FIGURE 5.8Cost per TB patient succe
Page 72 and 73:
FIGURE 5.10 Total cost and unit cos
Page 74 and 75:
● The 14 countries not included i
Page 76 and 77:
on public health by an external Exp
Page 78 and 79:
evised as a result of the introduct
Page 80 and 81:
TABLE 6.2 Incorporation of WHO poli
Page 82 and 83:
FIGURE 6.3The Supranational Referen
Page 84 and 85:
of TB disease by 65%, irrespective
Page 86 and 87:
FIGURE 7.3Percentage of TB patients
Page 88 and 89:
BOX 7.1Accelerating progress in pro
Page 90 and 91:
TABLE 7.2 Assumptions used to estim
Page 92 and 93:
FIGURE 8.1 The development pipeline
Page 94 and 95:
sputum specimens and TB isolates fr
Page 96 and 97:
cal trial sites and building labora
Page 98:
new TB vaccine candidate. A Phase I
Page 102 and 103:
This annex explains the methods tha
Page 104 and 105:
2011. On average, 15 data points we
Page 106 and 107:
may suffer from biases. These biase
Page 108 and 109:
TABLE A1.3Parameter estimates used
Page 110 and 111:
5. Estimates of TB prevalence, 1990
Page 112:
the Republic of Moldova, Romania, t
Page 116 and 117:
AFGHANISTANPopulation 2011 32 milli
Page 118 and 119:
BRAZILPopulation 2011 197 millionHI
Page 120 and 121:
CHINAPopulation 2011 1 348 millionH
Page 122 and 123:
ETHIOPIAPopulation 2011 85 millionH
Page 124 and 125:
INDONESIAPopulation 2011 242 millio
Page 126 and 127:
MOZAMBIQUEPopulation 2011 24 millio
Page 128 and 129:
NIGERIAPopulation 2011 162 millionH
Page 130 and 131:
PHILIPPINESPopulation 2011 95 milli
Page 132 and 133:
SOUTH AFRICAPopulation 2011 50 mill
Page 134 and 135:
UGANDAPopulation 2011 35 millionHIG
Page 136 and 137:
VIET NAMPopulation 2011 89 millionH
Page 138:
ANNEX 3Regional profiles
Page 141 and 142:
WHO REGION OF THE AMERICASPopulatio
Page 143 and 144:
WHO EUROPEAN REGIONPopulation 2011
Page 145 and 146:
WHO WESTERN PACIFIC REGIONPopulatio
Page 148 and 149:
SUMMARY BY WHO REGIONTable A4.1 Est
Page 150 and 151:
MORTALITY (EXCLUDING HIV) PREVALENC
Page 152 and 153:
NEW AND RELAPSENOTIFICATION RATE aY
Page 154 and 155:
-% OF TB PATIENTS WITHKNOWN HIV STA
Page 156 and 157:
AFRICAN REGIONTable A4.1 Estimates
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
INCIDENCE (INCLUDING HIV) INCIDENCE
Page 164 and 165:
NEW AND RELAPSENOTIFICATION RATE aY
Page 166 and 167:
NEW AND RELAPSENOTIFICATION RATE a1
Page 168 and 169:
TREATMENT SUCCESS (%) a1995-2010YEA
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
-% OF TB PATIENTS WITHKNOWN HIV STA
Page 176 and 177: YEARTOTALCONFIRMEDCASES OFMDR-TB aE
Page 178 and 179: MALEYEAR 0-14 15-24 25-34 35-44 45-
Page 180 and 181: REGION OF THE AMERICASTable A4.1 Es
Page 182 and 183: MORTALITY (EXCLUDING HIV) PREVALENC
Page 186 and 187: INCIDENCE (INCLUDING HIV) INCIDENCE
Page 188 and 189: NEW AND RELAPSENOTIFICATION RATE a1
Page 192 and 193: % OF COHORTTREATMENT SUCCESS (%) a1
Page 198 and 199: -% OF TB PATIENTS WITHKNOWN HIV STA
Page 202 and 203: MALEFEMALEYEAR 0-14 15-24 25-34 35-
Page 204 and 205: EASTERN MEDITERRANEAN REGIONTable A
Page 220 and 221: EUROPEAN REGIONTable A4.1 Estimates
Page 248 and 249: SOUTH-EAST ASIA REGIONTable A4.1 Es
Page 258: SMEAR LABS % OF SMEARPER 100K LABS
Page 261 and 262: Estimates of mortality, prevalence
Page 263 and 264: YEARPOPULATION(MILLIONS)MORTALITY (
Page 265 and 266: YEARPOPULATION(MILLIONS)INCIDENCE (
Page 267 and 268: YEARPOPULATION(MILLIONS)INCIDENCE (
Page 271 and 272: TREATMENT SUCCESS (%) a1995-2010YEA
Page 273 and 274: TREATMENT SUCCESS (%) a1995-2010YEA
Page 277 and 278:
YEARTOTALCONFIRMEDCASES OFMDR-TB aE
Page 279 and 280:
MALEFEMALEYEAR 0-14 15-24 25-34 35-
Page 281 and 282:
SMEAR LABS % OF SMEARPER 100K LABS
show all

Global Tuberculosis Report -- 2012.pdf

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?